Cargando…

Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis

PURPOSE: To report a case of choroidal carcinoid metastasis with neovascularization of the optic disc and macular edema that was treated with three sessions of intravitreal anti-vascular endothelial growth factor (anti-VEGF) as an adjuvant therapy with photodynamic therapy (PDT). METHODS: A 16-year-...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Saeed, Arabi, Amir, Shahraki, Toktam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861107/
https://www.ncbi.nlm.nih.gov/pubmed/33553848
http://dx.doi.org/10.4103/JOCO.JOCO_54_20
_version_ 1783647019618795520
author Karimi, Saeed
Arabi, Amir
Shahraki, Toktam
author_facet Karimi, Saeed
Arabi, Amir
Shahraki, Toktam
author_sort Karimi, Saeed
collection PubMed
description PURPOSE: To report a case of choroidal carcinoid metastasis with neovascularization of the optic disc and macular edema that was treated with three sessions of intravitreal anti-vascular endothelial growth factor (anti-VEGF) as an adjuvant therapy with photodynamic therapy (PDT). METHODS: A 16-year-old patient with a diagnosis of lung carcinoid tumor presented to an ophthalmology clinic with a complaint of decreased vision in his right eye. Fundus examination revealed choroidal carcinoid metastasis in addition to neovascularization of the optic disc. Macular optical coherence tomography revealed cystoid macular edema and subretinal fluid. The patient was treated with PDT in addition to three sessions of intravitreal anti-VEGF injections. RESULTS: Following the treatment, the new vessels regressed, and visual acuity improved. Furthermore, central retinal thickness reduced significantly. The tumor size reduced significantly over a follow-up period of 6 weeks. CONCLUSION: Choroidal carcinoid metastasis may be complicated by neovascularization of optic disc, which responds favorably to intravitreal injections of bevacizumab.
format Online
Article
Text
id pubmed-7861107
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-78611072021-02-05 Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis Karimi, Saeed Arabi, Amir Shahraki, Toktam J Curr Ophthalmol Case Report PURPOSE: To report a case of choroidal carcinoid metastasis with neovascularization of the optic disc and macular edema that was treated with three sessions of intravitreal anti-vascular endothelial growth factor (anti-VEGF) as an adjuvant therapy with photodynamic therapy (PDT). METHODS: A 16-year-old patient with a diagnosis of lung carcinoid tumor presented to an ophthalmology clinic with a complaint of decreased vision in his right eye. Fundus examination revealed choroidal carcinoid metastasis in addition to neovascularization of the optic disc. Macular optical coherence tomography revealed cystoid macular edema and subretinal fluid. The patient was treated with PDT in addition to three sessions of intravitreal anti-VEGF injections. RESULTS: Following the treatment, the new vessels regressed, and visual acuity improved. Furthermore, central retinal thickness reduced significantly. The tumor size reduced significantly over a follow-up period of 6 weeks. CONCLUSION: Choroidal carcinoid metastasis may be complicated by neovascularization of optic disc, which responds favorably to intravitreal injections of bevacizumab. Wolters Kluwer - Medknow 2020-12-12 /pmc/articles/PMC7861107/ /pubmed/33553848 http://dx.doi.org/10.4103/JOCO.JOCO_54_20 Text en Copyright: © 2020 Journal of Current Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Karimi, Saeed
Arabi, Amir
Shahraki, Toktam
Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
title Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
title_full Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
title_fullStr Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
title_full_unstemmed Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
title_short Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
title_sort intravitreal bevacizumab (avastin) as an adjuvant therapy for choroidal carcinoid metastasis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861107/
https://www.ncbi.nlm.nih.gov/pubmed/33553848
http://dx.doi.org/10.4103/JOCO.JOCO_54_20
work_keys_str_mv AT karimisaeed intravitrealbevacizumabavastinasanadjuvanttherapyforchoroidalcarcinoidmetastasis
AT arabiamir intravitrealbevacizumabavastinasanadjuvanttherapyforchoroidalcarcinoidmetastasis
AT shahrakitoktam intravitrealbevacizumabavastinasanadjuvanttherapyforchoroidalcarcinoidmetastasis